FHL3 Antikörper (Middle Region)
Kurzübersicht für FHL3 Antikörper (Middle Region) (ABIN928370)
Target
Alle FHL3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Schwein, Hund, Fruchtfliege (Drosophila melanogaster), Rind (Kuh), Frosch, Huhn
-
Aufreinigung
- Purified
-
Immunogen
- FHL3 antibody was raised in rabbit using the middle region of FHL3 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
FHL3 Blocking Peptide, (ABIN939223), is also available for use as a blocking control in assays to test for specificity of this FHL3 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- FHL3 (Four and A Half LIM Domains 3 (FHL3))
-
Andere Bezeichnung
- FHL3
-
Hintergrund
- FHL3 contains 4 LIM zinc-binding domains. It is expressed only in skeletal muscle. FHL3 association with MyoD may contribute to the regulation of MyoD-dependent transcription of muscle genes and thereby myogenesis.LIM proteins are defined by the possession of a highly conserved double zinc finger motif called the LIM domain. Synonyms: Polyclonal FHL3 antibody, Anti-FHL3 antibody, four and a half LIM domains 3 antibody, MGC19547 antibody, MGC23614 antibody, MGC8696 antibody, SLIM2 antibody.
Target
-